NEW YORK, June 24, 2025 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and
NEW YORK, June 24, 2025 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and
DALLAS, June 24, 2025 /PRNewswire/ -- IVX Health, a national provider of outpatient infusion and injection centers, today announced its
DALLAS, June 24, 2025 /PRNewswire/ -- IVX Health, a national provider of outpatient infusion and injection centers, today announced its
SCOTTSDALE, Ariz., June 24, 2025 /PRNewswire/ -- Summit Health Advisors, LLC has been awarded a $98,000 grant from the NCPDP
SCOTTSDALE, Ariz., June 24, 2025 /PRNewswire/ -- Summit Health Advisors, LLC has been awarded a $98,000 grant from the NCPDP
Sutacimig Phase 2 interim results demonstrate >50% reduction in treated bleeding event and prophylactic treatment potential in Glanzmann thrombasthenia HMB-002
Sutacimig Phase 2 interim results demonstrate >50% reduction in treated bleeding event and prophylactic treatment potential in Glanzmann thrombasthenia HMB-002
PALM BEACH GARDENS, Fla., June 24, 2025 /PRNewswire/ -- A second child has died after receiving Elevidys, an experimental gene
PALM BEACH GARDENS, Fla., June 24, 2025 /PRNewswire/ -- A second child has died after receiving Elevidys, an experimental gene